Abstract
Background: Hypotension is the most common adverse event when subarachnoid anesthesia is administered for cesarean section; multiple strategies for its prevention and management have been proposed, including the use of prophylactic vasopressors with inconclusive results. Objective: To evaluate the preventive efficacy of the use of phenylephrine in hypotension induced by subarachnoid anesthesia in pregnant women taken to caesarean section. Methods: A double-blind, controlled clinical trial in pregnant women, older than 18 years old, ASA 1 and 2, who received a subarachnoid anesthesia for cesarean section, were randomized to receive placebo or prophylactic infusion of phenylephrine 40 mcg / min, for 5 minutes. Results: 140 patients were included in data analysis. Incidence of hypotension was higher in the control group than in the intervention group (AR 45.71% vs 32.85%). There were no significant differences between the two groups (p= 0.119). RR of hypotension in the intervention group were lower, independent of the criterion of hypotension [systolic blood pressure, RR 0.72 (95% CI 0.47-1.09), mean arterial pressure, RR 0.93 (95% CI 0.64-1.37), SBP or MAP 0.86 (RR 0.86) (IC95% 0.62-1.21)], but without significant differences p> 0.05. The use of vasopressors in patients who presented this event occurred in 75.4% (n = 52), with higher RR in the control group and significant differences when evaluating the two groups. (RR 1.4 p = 0.032). Conclusions: Prophylactic phenylephrine did not prove effective in reducing the incidence of hypotension, however, it is associated with a significant decrease in vasopressor requirements, as well as in the incidence of nausea and vomiting. MÉD.UIS. 2018;31(2):33-9.
References
2. Rubio-Romero JA, Fonseca-Pérez JE, Molina S, Buitrago-Leal M,Zuleta JJ, Ángel-Müller E, et al. Racionalización del uso de la cesárea en Colombia. Consenso de la Federación Colombianade Obstetricia y Ginecología (FECOLSOG) y la Federación Colombiana de Perinatología (FECOPEN). Bogotá, 2014. Rev Colomb Obstet Ginecol. 2014;65(2):139–51.
3. Williams JW. Obstetrics: A Texbook for the Use of Students and Practitioners. New York : Appleton and Company.
4. Chestnut DV, Wong CA, Tsen L, Ngan Kee W, Beilin Y, Mhyre J. Chestnut’s Obstetric Anesthesia: Principles and Practice. Philadelphia: Elsevier; 2014.
5. Miler, RD. Miller’s Antesthesia. 8a ed. España: Elsevier; 2016.
6. KlÖhr S, Roth R, Hofmann T, Rossaint R, Heesen M. Definitions of hypotension after spinal anaesthesia for caesarean section: Literature search and application to parturients. Acta Anaesthesiol Scand. 2010;54(8):909–21
7. Mavridou I, Stewart A, Fernando R. Maternal Hypotension During Spinal Anesthesia for Cesarean Delivery. Curr Anesthesiol Rep. 2013;3(4):282–91.
8. Chooi C, Cox JJ, Lumb RS, Middleton P, Chemali M, Emmett RS, et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev.2010;(3):11.
9. Ouerghi S, Bougacha MA, Frikha N, Mestiri T, Ben Ammar MS, Mebazaa MS. Combined use of crystalloid preload and low dose spinal anesthesia for preventing hypotension in spinal anesthesia for cesarean delivery: A randomized controlled trial. Middle East J Anesthesiol. 2010;20(5):667-72.
10. Dyer RA, Farina Z, Joubert IA, Du Toit P, Meyer M, Torr G, et al. Crystalloid preload versus rapid crystalloid administration after induction of spinal anesthesia for elective cesarean section. Anaesth Intensive Care. 2004;32(3):351-7.
11. Banerjee A, Stocche RM, Angle P, Halpern SH. Preload or coload for spinal anesthesia for elective Cesarean delivery: A metaanalysis. Can J Anaesth. 2010;57(1):24-31.
12. Arzola C, Wieczorek PM. Efficacy of low-dose bupivacaine in spinal anaesthesia for Caesarean delivery: systematic review and meta-analysis. Br J Anaesth. 2011;107(3):308–18.
13. Gupta S. Vasopressors and tight control of maternal blood pressure during cesarean delivery: A rocky Alliance. J Anaesthesiol Clin Pharmacol. 2013;29(1):1-3.
14. Dyer RA, Biccard BM. Ephedrine for spinal hypotension during elective caesarean section: the final nail in the coffin? Acta Anaesthesiol Scand. 2012;56(7):807-9.
15. Ngan Kee WD, Khaw KS, Tan PE, Ng FF, Karmakar MK. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology. 2009;111(3):506-12.
16. Heesen M, Klöhr S, Rossaint R, Straube S. Prophylactic phenylephrine for caesarean section under spinal anaesthesia: Systematic review and meta-analysis. Anaesthesia.2014;69(2):143–65.
17. Habib AS. A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg. 2012;114(2):377–90.
18. Stewart A, Fernando R, McDonald S, Hignett R, Jones T, Columb M. The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesth Analg. 2010;111(5):1230-7.
19. Mahajan L, Anand LK, Gombar KK. A randomized doubleblinded comparison of ephedrine, phenylephrine and mephentermine infusions to maintain blood pressure during spinal anaesthesia for cesarean delivery: the effects on fetal acid-base status and haemodynamic control. J anaesthesiol clin pharmacol. 2009;25(4):427-32.
20. Ngan WW, Khaw K, Ng FF. Prevention of hypotension during spinal anesthesia for cesarean delivery. an effective technique using combination phenylephrine infusion and crystalloid cohydration. Anesthesiology. 2005;103(4):744–50.
21. Allen TK, George RB, White WD, Muir HA, Habib AS. A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery. Anesth Analg. 2010;111(5):1221–9.
22. Ngan Kee. Phenylephrine Infusions for Maintaining Blood Pressure During Spinal Anesthesia for Cesarean Delivery: Finding the Shoe That Fits. Anesth Analg. 2014;118(3):496-498.
23. Doherty A, Ohashi Y, Downey K, Carvalho J. Phenylephrine Infusion Versus Bolus Regimens During Cesarean Delivery Under Spinal Anesthesia: A Double-Blind Randomized Clinical Trial to Assess Hemodynamic Changes. Anesth Analg. 2012;115(6):1343-1350.
24. World Medical Association. World Medical Association Declaration of Helsinki-Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.
25. Resolución 8430 de 1993. Colombia. Ministerio de Salud. 1993:1–19.
26. Ley estatutaria 1581 de 2012. Colombia. Congreso de la República. 2012.
27. Pinder AJ, Dresner M, Clow C, Shorten GD, O’Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11 (3):156-15.
28. American Society of Anesthesiologists. Practice Guidelines for Obstetric Anesthesia. ASA. 2016;24(2):270-300.
29. SOAP. Practice Guidelines for Obstetric Anesthesia. Vol. 124, Anesthesiology. 2016. 270-300